Recurrent chronic thromboembolic disease despite optimal anticoagulation in setting of recent COVID-19 infection.

Recurrent chronic thromboembolic disease despite optimal anticoagulation in setting of recent COVID-19 infection.

Vittorio Romeo Terrigno, Daniel Anthony Ricketti, Pranav Patel, Satyajeet Roy

We present a case of a 38-year-old man with a history of chronic thromboembolic pulmonary hypertension on therapeutic anticoagulation and recent hospitalisation for COVID-19 disease who was hospitalised for recurrent acute pulmonary embolism despite therapeutic anticoagulation with warfarin (International Normalized Ratio (INR) of 3.0). Our case highlights the hypercoagulable state associated with COVID-19 disease and the absence of standardised approaches to anticoagulation treatment for this population.

2021

infectious diseases, Pulmonary Embolism, venous thromboembolism, haematology (drugs and medicines)

10.1136/bcr-2020-238733

BMJ case reports